A high JAK2 V617F allele burden (> 75%) was associated with a 3.56-fold higher relative risk (95% CI, 1.47–7.1; P = .004) of total thrombosis compared with a reference population. The gene discussed is JAK2; the disease is deep vein thrombosis.